PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

My Letter to the Editor of New York Times on Epipen and Personal Drug Importation

Talking to the New York Times!

Talking to the New York Times!

Last week the New York Times published my Letter to the Editor in response to an article about Mylan’s despicable increase of the life-saving drug Epipen, which saves people from serious allergic reactions. In “An Outcry Over the Price of Epipen,” my Letter’s focus is really on Congress and the need for them to actually do something besides talk.  I note that personal drug importation, which is already happening, should not just be tolerated as a technically illegal behavior for which patients are never prosecuted but encouraged using proper guidance so that people can afford the prescriptions they need.

The other Letters provide excellent contributions to the policy debate.  Caroline Poplin, who is a doctor, lawyer and healthcare analyst (wow!), criticizes drug companies for their abuse of our patent laws and federal regulations that allow them to maximize profits over patients. She believes that where the market is producing “bad results” government ought to provide remedies.

Sarah fink writes that due to the price of Epipen, her serious allergic reaction forced the plane she was on to land! Here we learn that airlines started cutting back on keeping Epipens on places due to the price. This was my favorite Letter.

Again, check it out here.

Share
Tagged with: , , ,

How to Afford EpiPen with a Safe International Online Pharmacy

The price of the lifesaving injection Epinephrine, which is prescribed for people with serious allergies, is out of control, surging by 480% . . The lowest price for two injections at a PharmacyChecker.com-approved online pharmacy is just over $200.

By Intropin (Own work), Creative Commons via Wikimedia Commons [(CC BY 3.0)]

The price of the life-saving injection epinephrine, which is prescribed for people with serious allergies, is out of control, surging by 480% since 2009, CBS News reports. But American parents are actually choosing to forgo buying it because of the cost. Enough! For EpiPen Jr, the brand usually prescribed to kids, the lowest price U.S. option found on GoodRx is $614 for a package of two. The lowest price for two injections at a PharmacyChecker.com-approved online pharmacy is just over $200. That means a potential $400 – 66% – savings. Much more than the numbers: for some parents this is the difference between buying or not buying a medication that can save their kid’s life.

I’m a parent and this makes me sick and angry. But what will doubly disgust me today is if I read some Pharma-funded bull about unsafe medication in other countries that might scare a parent away from lower cost Epinephrine. This is life and death for kids. Only the truth is acceptable. The EpiPen Jr is marketed by generic drug giant Mylan in the U.S. But lower cost options internationally are either manufactured or licensed by Pfizer, the drug’s innovator, which should take the wind out of the sails of bogus arguments about “foreign drugs.”

 

Share
Tagged with: , ,